Last week →  The opposition's star witness conceded Schedule III

The rescheduling hearing is over. Now the waiting begins — briefs due August 17.

Seventeen hearing days after it opened, the DEA's administrative hearing on moving marijuana to Schedule III closed on Wednesday, July 15, with final presentations from the opposing states. The next day, Chief Administrative Law Judge Derek Julius set the only firm date left on the calendar: post-hearing briefs — up to 50 pages, closing arguments included — are due August 17. After that, Julius writes his recommendation on no fixed schedule, and the DEA administrator makes the final call. Nothing about marijuana's federal status changed this week, and the parallel fight continued: the nine parties challenging April's interim Schedule III order asked the D.C. Circuit to keep medical cannabis businesses out of the case. For operators, the guidance is unchanged and unglamorous — keep §280E reserves intact, document everything, and treat every "rescheduling is done" headline as premature until a final rule survives review.

Why it matters: The hearing was the last scheduled event in the rescheduling process. From here, timing is entirely discretionary — the ALJ recommendation and the administrator's final rule carry no deadlines, and any rule faces near-certain litigation. Operators building 2026–27 budgets should not book §280E relief against any assumed date. Talk to your counsel before changing tax positions.

The hearing closed July 15 after final presentations by the opposing states; reporting from the last days says the states' own witness conceded regulated markets reduce illicit-market crime. ALJ Derek Julius's July 16 order set August 17 for post-hearing briefs (50-page cap). Separately, the anti-rescheduling plaintiffs asked the D.C. Circuit to deny medical cannabis businesses intervention in the challenge to April's interim order.

Why it matters: The November 12 federal hemp redefinition — 0.4 mg total THC per container — remains the single largest threat to the hemp product economy. CAOA is a long-odds vehicle, but it now contains an explicit recriminalization block, and Sen. Sheehy's comments are the clearest Republican signal yet that a narrower bipartisan fix is being drafted. Inventory and SKU planning should still assume the deadline holds.

Sens. Schumer, Booker and Wyden, with 14 Democratic cosponsors, refiled the Cannabis Administration and Opportunity Act on July 16 — federal legalization and taxation, plus a provision preventing November's scheduled hemp THC recriminalization. The same day, Sen. Tim Sheehy (R-MT) said keeping hemp THC products legal "can unite lawmakers" and pointed to forthcoming bipartisan legislation. No text or timeline has been released.

Why it matters: The memo is a reminder that rescheduling changes tax and research law, not employment law. Employers with federal contracts, security clearances, or DOT-regulated workforces should expect the same pattern: agency policies restricting use survive a scheduling change unless separately amended. Update employee-facing guidance so staff don't read rescheduling headlines as permission.

The Department of War issued a memo warning service members that marijuana use and possession "remain punishable" under the Uniform Code of Military Justice notwithstanding the administration's rescheduling moves.

Why it matters: The injunction covers exactly 10 plaintiff companies — their products can flow while every other intoxicating hemp beverage remains restricted under SB 56. Ohio retailers now carry legally distinct inventory side by side, and the AG's stay motion could flip the rules again within days. Distributors and retailers should track plaintiff status at the SKU level and talk to counsel before restocking.

U.S. District Judge Jeffrey Helmick granted a preliminary injunction on July 13 blocking SB 56 hemp-beverage enforcement against the 10 companies that sued, finding the law likely discriminates unconstitutionally in favor of in-state licensees. Attorney General Andy Wilson moved for a stay the next day, citing market uncertainty.

Why it matters: A public reporting channel changes the enforcement math: complaints can now come from competitors, landlords, or customers, not just inspectors. Combined with the August 15 cap — 2 mg total THC per package to remain "hemp" in Virginia — multistate brands shipping into the commonwealth have four weeks to rescope SKUs or exit shelves. This is the nearest hard deadline in the country.

The Cannabis Control Authority launched an online form and tip line for reporting suspected violations of the new legalization law, saying every report helps "investigate potential violations and protect public health and safety." The 2 mg per-package total-THC hemp cap takes effect August 15.

Why it matters: Filed the same week the Ohio injunction landed, the Missouri suit suggests a coordinated litigation playbook against state intoxicating-hemp crackdowns — constitutional challenges in federal court rather than statehouse lobbying. If the Ohio reasoning travels, state hemp restrictions with in-state carve-outs are the most exposed. Watch for copycat filings.

Missouri hemp businesses filed a federal lawsuit challenging the new hemp product restrictions enacted under HB 2641. Details of the claims are still emerging.

Why it matters: Idaho stays one of the last full-prohibition states, and the criminal referral raises the stakes for future signature campaigns everywhere — petition-gathering practices are now themselves an enforcement target. Campaigns in restrictive states should treat signature-vendor compliance as a legal-risk item, not a logistics item.

The secretary of state detailed his determination that the medical cannabis campaign fell short of valid signatures for the November ballot, and referred possible illegal petitioning conduct to the Idaho State Police for "review and potential criminal investigation."

Why it matters: Two mature markets, two product-integrity actions in one week — one for exceeding THC potency limits, one for pesticides above allowable levels. Recalls of this type increasingly start from regulator data audits rather than complaints. Cultivators and processors should re-verify COA-to-label consistency and pesticide sourcing records before regulators do it for them.

Michigan's Cannabis Regulatory Agency announced a voluntary recall of Fantasy Farms LLC products that exceed THC potency limits. Colorado regulators issued a health-and-safety advisory for marijuana products carrying pesticide residues above acceptable limits.

Why it matters: Religious-liberty challenges have cracked prohibition in a handful of Caribbean jurisdictions; Kenya's ruling shows African courts holding the line. For operators watching East Africa as a future cultivation region, judicial reform paths look closed — change there will have to come through legislation.

Kenya's High Court dismissed a petition by Rastafarian adherents to decriminalize cannabis on religious grounds, upholding the country's criminal prohibition.

Why it matters: Spain's medical cannabis framework has moved slowly since its 2023 approval; a first product registration makes the pathway real rather than theoretical. For European operators, it signals Spain is finally standing up a pharmacy-dispensed model — and that first-mover registrations will shape the specification standards everyone else must meet.

Curaleaf announced Spanish authorities approved registration of two standardized cannabis preparations — reported as the first such registrations under Spain's medical cannabis framework.

With CAOA's hemp provision and the Sheehy signal both pointed at November 12, the question is whether anything actually stops the federal hemp redefinition. Our explainer on the White House delay question lays out what the deadline does, who it hits, and the realistic paths to averting it. Read the summary →